Bifidobacterium pseudocatenulatum is associated with atopic eczema: A nested case-control study investigating the fecal microbiota of infants

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 1, 2008, Pages 135-140

  Gore, Claudia ^a   Munro, Karen ^b   Lay, Christophe ^b   Bibiloni, Rodrigo ^b   Morris, Julie ^a   Woodcock, Ashley ^a   Custovic, Adnan ^a   Tannock, Gerald W ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

allergy; atopic dermatitis; atopy; bifidobacteria; Eczema; fecal bacterial community; gastrointestinal; microbiota; microflora

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; NUCLEIC ACID BASE; PROTEIN X;

ARTICLE; ATOPIC DERMATITIS; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BOTTLE FEEDING; BREAST FEEDING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DISEASE SEVERITY; DRUG EXPOSURE; ETHNICITY; FAMILY HISTORY; FECES ANALYSIS; FECES COMPOSITION; FECES MICROFLORA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANCY; INFANT; INFORMATION PROCESSING; INTESTINE MUCOSA PERMEABILITY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; URINALYSIS;

ADULT; BIFIDOBACTERIUM; BREAST FEEDING; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; ELECTROPHORESIS, AGAR GEL; EOSINOPHIL-DERIVED NEUROTOXIN; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN E; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT FORMULA; MALE; SEVERITY OF ILLNESS INDEX;

EID: 38349057307     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.07.061     Document Type: Article

References (24)

1. Hopkin J.M. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr Opin Immunol 9 (1997) 788-792
2. Murray C.S., and Woodcock A. Gut microflora and atopic disease. In: Tannock G.W. (Ed). Probiotics and prebiotics: where are we going? Wymondham (2002), Caister Academic Press, United Kingdom 239-261
3. Brandtzaeg P. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann N Y Acad Sci 964 (2002) 13-45
4. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., and Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108 (2001) 144-145
5. Sepp E., Julge K., Vasar M., Naaber P., Bjorksten B., and Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86 (1997) 856-961
6. Harmsen H.J.M., Wildboer A.C.M., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30 (2000) 61-67
7. Young S.L., Simon M.A., Baird M.A., Tannock G.W., Bibiloni R., Spencely K., et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diag Lab Immunol 11 (2004) 686-690
8. Williams H.C., Burney P.G., Hay R.J., Archer C.B., Shipley M.J., Hunter J.J., et al. The UK Working Party's diagnostic criteria for atopic dermatitis, I: derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131 (1994) 383-396
9. Severity scoring of atopic dermatitis: the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology 186 (1993) 23
10. Peterson C.G., Eklund E., Taha Y., Raah Y., and Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 97 (2002) 1755-1762
11. Akram S., Mourani S., Ou C.N., Rogerud C., Sadiq R., and Goodgame R.W. Assessment of intestinal permeability with a two-hour urine collection. Dig Dis Sci 43 (1998) 1946-1950
12. Fleming S.C., Kapembwa M.S., Laker M.F., Levin G.E., and Griffin G.E. Rapid and simultaneous determination of lactulose and mannitol in urine by HPLC with pulsed amperometric detection for use in studies of intestinal permeability. Clin Chem 36 (1990) 797-799
13. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., et al. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl Environ Microbiol 70 (2004) 2129-2136
14. Tannock G.W., Munro K., Harmsen H.J.M., Welling G.W., Smart J., and Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66 (2000) 2578-2588
15. Amann R.I., Krumholz L., and Stahl D.A. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol 172 (1990) 762-770
16. Wallner G., Amann R., and Beisker W. Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14 (1993) 136-143
17. Langendijk P.S., Schut F., Jansen G.J., Raangs G.C., Kamphuis G.R., Wilkinson M.H., et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61 (1995) 3069-3075
18. Lay C., Riggotier-Gois L., Holmstrom K., Rajilic M., Vaughan E.E., de Vos W.M., et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 71 (2005) 4153-4155
19. Lay C., Sutren M., Rochet V., Saunier K., Dore J., and Rigottier-Gois L. Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol 7 (2005) 933-946
20. Requena T., Burton J., Matsuki T., Munro K., Simon M.A., Tanaka R., et al. Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol 68 (2002) 2420-2427
21. Zoetendal E.G., Akkermans A.D., and de Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64 (1998) 3854-3859
22. Murray C.S., Tannock G.W., Simon M.A., Harmsen H.J.M., Welling G.W., Custovic A., et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 35 (2005) 741-745
23. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., and Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107 (2001) 129-134
24. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., and Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30 (2001) 43-47